Treatment preferences varied widely among patients with inflammatory bowel disease but were largely influenced by a desire for reduction in abdominal pain, according to data from the P-POWER IBD study presented at the ACG Annual Scientific Meeting.

Corey A. Siegel, MD, MS, section chief of gastroenterology and hepatology, co-director of the Inflammatory Bowel Disease Center and professor of medicine at Dartmouth-Hitchcock Medical Center, and colleagues used an online cross-sectional survey to collect data on treatment preferences from 400 patients aged 18 to 78 years with Crohn’s disease

Full Article: